Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 3/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | DPP4 | P27487 | 2/20 | 0.33 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | GABRP | O00591 | 2/20 | 0.32 |
| ▸ | GABRD | O14764 | 2/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.32 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2241803 | 0.89 | LMNA (0.46) | SLC1A1TSHRLMNAKMT2ADPP4 | |
| SCHEMBL4537585 | 0.89 | LMNA (0.46) | SLC1A1TSHRLMNAKMT2ADPP4 | |
| SCHEMBL16523558 | 0.85 | LMNA (0.43) | SLC1A1TSHRLMNADPP4DPP8 | |
| SCHEMBL1318285 | 0.84 | SLC1A1 (0.55) | SLC1A1TSHRLMNAKDM4EKMT2A | |
| SCHEMBL131050 | 0.84 | SLC1A1 (0.55) | SLC1A1TSHRLMNAKDM4EKMT2A | |
| SCHEMBL131049 | 0.84 | SLC1A1 (0.55) | SLC1A1TSHRLMNAKDM4EKMT2A | |
| SCHEMBL14175423 | 0.84 | CYP1A2 (0.44) | SLC1A1LMNAKMT2AGABRPGABRD | |
| SCHEMBL31229067 | 0.84 | CYP1A2 (0.44) | SLC1A1LMNAKMT2AGABRPGABRD | |
| Hydrochloric Acid SCHEMBL624146 | 0.82 | SLC1A1 (0.53) | SLC1A1TSHRLMNAKDM4EKMT2A | |
| Hydrochloric Acid SCHEMBL1238805 | 0.82 | SLC1A1 (0.53) | SLC1A1TSHRLMNAKDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10829454-B2 | Compositions and methods for the treatment of Parkinson's disease | CELLIX BIO PRIVATE LIMITED (IN) | 2020-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10829454-B2 | Compositions and methods for the treatment of Parkinson's disease | PARK7, SNCA, SLC6A3 | SLC1A1 523/4885TSHR 2918/4885LMNA 1211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.